Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy

• DOI: 10.1126/sciadv.aba5628
• Publication Date: 2020-09-04T23:12:38Z
• Authors: L. Ringgaard; F. Melander; R. Eliasen; J. R. Henriksen; R. I. Jølck; T. B. Engel; M. Bak; F. P. Fliedner; K. Kristensen; D. R. Elema; A. Kjaer; A. E. Hansen; T. L. Andresen
• Keywords: 0303 health sciences; Antineoplastic Agents; 3. Good health; 03 medical and health sciences; Drug Delivery Systems; Cell Line, Tumor; Neoplasms; Liposomes; Tumor Microenvironment; Humans; Immunologic Factors; /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being; Immunotherapy; Research Articles

Liposomal oxaliplatin remodels the tumor microenvironment and potentiate TLR-agonist–mediated immune responses in cancer.